Embed Size (px)
Citation preview
Wissen schafft Gesundheit
OncologyUKSH Spezial
UNIVERSITÄTSKLINIKUMSchleswig-Holstein
Bil
d: ©
Kim
Sch
neid
er@
foto
lia.c
om
UKSHUKSH
Impressum:Publisher: UKSH | Editorial V.i.S.d.P.: Oliver GrieveGraphic Designer: Guido Weinberger, 2016
2
Editorial ...................................................................................................5
Cancer Center North ........................................................................... 7
Gynecology.............................................................................................9
General Surgery ...................................................................................11
Pulmonology ........................................................................................ 13
Urology .................................................................................................. 15
ENT ......................................................................................................... 17
Dermatology ........................................................................................ 19
Neurosurgery ..................................................................................... 21
Hematology ........................................................................................23
Radiology, Nuclear Medicine and Radiotherapy ........................25
Inhalt
Bil
d: n
iyaz
z@fo
tolia
.com
Dear Patients,
the treatment of cancer is a major challenge for physicians - in the diagnosis, therapy and post-operative care for inpatients and outpatients. The complex nature of cancer and its possible occurrence in every organ makes it necessary for hospitals to have both clear guidance from science and the ability to provide excellent patient care. It is our common responsibility to offer patients the highest level of safety in cancer treatment – from both somatic and psychosocial perspectives. The oncological disciplines at University Hospital Schleswig-Holstein have therefore decided to take a comprehensive quality offensive stance. This is illustrated by the considerable efforts that we have implemented for the certification of 13 organ cancer centers. Our cancer centers meet the highest technical requirements of the German Cancer Society for a certified Oncological Center and have received the full recommendation of the German Cancer Society. The excellent interdisciplinary cooperation of all disciplines is the guarantee of an optimal diagnosis and treatment for our patients.We hope you will get well soon! Best regards,
Prof. Dr. Jens Scholz, MBACEO, UKSH
Prof. Dr. Jens Scholz
Editorial
4
5
UKSHUKSH
Cancer Center North
Comprehensive Cancer CenterThe Cancer Center North is an academic cancer center of Schleswig-Holstein supported by UKSH and the medical faculties of Universities in Kiel and Lübeck.
A majority of the largest hospitals in the country are cooperating members of the Cancer Center North. The Center has almost 70 percent of all hospitalized cancer patients in Schleswig-Holstein who are treated after a cancer diagnosis and receive treatment according to the therapy standards of CCC. This favorable situation is a special feature in Germany and assures optimal, univer-sal coverage. In Cancer Center North, many doctors and scientists are trying to incorporate new scientific deve-lopments and findings in order to optimize therapy.
The German Cancer Society has certified both the UKSH Campuses Kiel and Lübeck together with more than 80 university clinics and scientific institutes. Our patients can be confident that they will benefit from the expertise from all cancer care disciplines and will be treated according to the latest standards in medicine. In addition to interdisciplinary patient care, the Oncology Center assures that evidence-based quality criteria are met and patients have access to clinical trials and that everyone concerned is involved in the follow up. The core of the Oncology Center is based on case conferences for the patients called tumor boards. At these boards, experts discuss a patient’s complex medical condition, and a common treatment strategy is outlined for each individual patient. The Oncology Center is also involved in a number of clinical trials in which patients - if they agree - either receive the standard treatment or a new treatment option. These studies further research and have led in recent years to many new cancer treatments. A key scientific focus is on translational research. This is based on scientific evidence and has concrete application targets and individual treatment.
Organ Cancer CentersCampus Kiel• Breast Cancer Center• Cancer Center• Gynecological Cancer Center• Skin Cancer Center• Lung Cancer Center• Prostate Center• Pancreatic Cancer Center• Head and Neck Tumor Center• Pancreatic Cancer Center• Gastrointestinal TumorsCampus Lübeck• Breast Cancer Center• Cancer Center• Gynecological Cancer Center• Skin Cancer Center• Lung Cancer Center• Head and Neck Tumors• Pancreatic Cancer Center• Gastrointestinal Tumors• Lymphomas and Hematologic Tumors German Cancer Prize for UKSH Doctors1992: Walter Jonat, Director of the Department of
Obstetrics and Gynecology, Campus Kiel2011: Axel Hauschild, Head of Focal Area Derma-
Oncology and Dermatologic Surgery in the Department of Dermatology, Venereology and Allergology, Campus Kiel
2013: Alexander Katalinic, Director of the Institute for Social Medicine and Epidemiology, Campus Lübeck and the Institute of Cancer Epidemiology e.V., University of Lübeck
2014: Martin Schrappe, Director of the Department of General Pediatrics, Campus Kiel
2015: Günter Klöppel, Emeritus, former Director of the Institute of Pathology, Campus Kiel
6
77
Bil
d: ©
Jon
as G
laub
itz
- Fo
toli
a.co
m
Gynecology
Breast and Genital Cancer CenterThe UKSH clinics for Gynecology belong to the Centers of Excellence in Germany, where leading translational research is carried out in gynecologic oncology. In addition, The German Cancer Society certifies the Oncological Center, Organ Cancer Centers, Breast Cancer Center, and Breast Cancer Center and Genital Cancer. The UKSH Cancer Centers are among the largest of their kind in Germany. The infrastructure facilitates the care of women with cancer and has transparent features and access to the most qualitative, innovative and modern cancer treatment methods.
Breast CancerApproximately 400 breast cancer cases are treated at both sites annually. Interdisciplinary collaboration begins at the time of diagnosis: The findings of the experts in the field of breast imaging are discussed with pathologists and surgeons. Doctors can then employ an entire arsenal of established diagnostic procedures. In addition, new methods such as tomosynthesis, a UKSH co-developed method which is instrumental in accurate representation of mammographic findings, or magnetic resonance imaging of the breast and genitals can be used for critical issues, in order to optimize the surgical treatment or even prevent unnecessary operations.
Genital CancerGenital cancers affect various organs of the external and internal genitalia. However, depending on their origin and their histological structure these diseases are very different and are individually treated both diagnostically and therapeutically. The UKSH Genital Cancer Centers work in close cooperation with the Department of Radiotherapy and have a key function in ensuring patients the greatest possible security with minimal impact on adjacent organs. The latest laparoscopic instruments with high-resolution cameras enable us to define preparation along important anatomical structures and the complete removal of the diseased tissue without a large abdominal incision. This includes the testing of new tools and surgical techniques and the use of the most advanced surgical
robot (da Vinci system). Operations for ovarian cancer also have a very high priority. Success is crucial for the prognosis of affected patients. Ovarian cancer is often at an advanced stage at the time of diagnosis with involvement of the peritoneum and other organs. The goal of a successful operation is the complete removal of all visible tumors and requires an interdisciplinary team of gynecological oncologists, surgeons and urologists.
Abdominal and Thoracic SurgeryMinimally invasive surgery: The majority of the esophagus, stomach, liver and intestinal surgery is performed using minimally invasive techniques in the Department of General Surgery, Visceral, Thoracic, Transplantation and Pediatric Surgery at Campus Kiel. The clinic has extensive experience in this area. More than 2/3 of 400 procedures were performed with minimally invasive intestinal surgery. Even the largest cancer surgery, performed on the esophagus, was done in 70 percent of the cases with laparoscopically assisted surgery.
Robot-Assisted Surgical TechniqueThe robot-assisted, minimally invasive surgical tech-niques offer advantages over conventional laparoscopic surgery. The robot-assisted surgery offers the possibi-lity of precise anatomical structure representation by a three-dimensional view and up to 10x magnification. The motion of the surgeon's hand is converted into fine and fully jitter-free movements to the preparation instruments. This minimizes tissue damage and the smallest nerves and blood vessels are spared. The robot-assisted Da Vinci System® has been in operation on the UKSH, Campus Kiel since 2013. The robot-assisted system has already been used with very good results in a number of cancer surgeries. Meanwhile, the range has been extended and applied in very complex cancer sur-geries. For the first time in Germany, the Department of General Surgery and Thoracic Surgery has succeeded in removing a cancerous esophagus by using only robot-assisted surgery.
UKSHUKSH
88
9
General Surgery Campus LübeckCampus Lübeck
GI-Tumors The focus of the Department of General Surgery at Campus Lübeck is on visceral and thoracic oncology surgery. This concerns the special areas of colorectal surgery, hepato-pancreatobiliary surgery, surgery of the esophagus and the peripheral and retroperitoneal sarcomas. The clinic enjoys a nationwide reputation in colorectal surgery and hepatopancreatic surgery.
The German Society of General and Visceral Surgery recognized the clinic in 2013 as a Center of Excellence for Coloproctology. The Clinic has a special emphasis in the treatment of colorectal cancer and the use of minimally invasive techniques. The Clinic is far above the national average (about 85 percent) in using minimally invasive techniques for the treatment of colon cancer. The Department of General Surgery in pancreas surgery also enjoys nationwide visibility.The interdisciplinary regimen in oncological treatment is particularly reflected in the treatment of metastases. Here the most modern techniques of surgical armamentariums including minimally invasive thoracoscopic surgery (VATS lobectomy) and laparoscopic liver surgery including navigated laparoscopic liver surgery are available for liver surgery and in thoracic surgery. The clinic has facilities for thermal ablation of metastases by RFTA and laser surgery for the removal of pulmonary metastases and liver metastases.
OncologyThe Medical Clinic I at Campus Lübeck treats about 2,000 patients in the hematology/ oncology clinic each year. We offer the entire range of internal medicine hematology / oncology. An excellently functioning interdisciplinary network is an important part of our work. In the inpatient area, the focus is on the treatment of hematological diseases, with an option of stem cell transplantation (autologous and allogeneic). An important outpatient aspect of our hemato-oncology department is the treatment of gastrointestinal tumors and colorectal cancer, in particular tumors of the gastro-oesophageal transition and stomach.
Campus Lübeck is well-suited for the care of patients with neuroendocrine neoplastic tumors since it is an interdisciplinary NEN-center.
10
11
Bil
d: ©
Jon
as G
laub
itz
- Fo
toli
a.co
m
Lung CancerThe UKSH pulmonology departments feature the full range of diagnostic and therapeutic methods for treating lung tumors. In order to precisely diagnose the tumors before surgery, elaborate tests are necessary. Computed tomography allows, high resolution and low radiation exposure. Minimum densities in the lung parenchyma can be exactly evaluated by short-term reinvestigations to look at their growth behavior. For larger changes, a histological examination is the way to decide the best course of action. Changes in the lung periphery can be seen from the outside under CT guidance. An elegant and low risk alternative, histology is done during a lung (bronchoscopy) under CT guidance. The excellent interdisciplinary cooperation between pulmonology and radiology method has developed into routine procedure at UKSH.
The lymph node findings often decide whether a patient is operable and potentially curable. After surgical removal of the actual lung tumor, the lymph nodes are examined for potential cancer scatter points. Therefore, all patients are examined before elective surgery with the help of special PET-CT. Another last precaution is however, a cytological or histological examination. The tumor board looks at the patient’s tumor stage and creates the best treatment approach.
Campus Kiel has developed the parenchymsparender process for the surgical treatment of lung cancer. That means oncology radically operated cancers can be treated by resection techniques so that as much as possible "healthy" lung tissue can be preserved. Campus Lübeck has great expertise in minimally invasive surgery. The central point is the VATS (Video-Assisted Thoracoscopic Surgery) -Lobectomy for lung cancer. This video-assisted process is extremely gentle on the patient.
Campus KielCampus Kiel
Pulmonology
PET-CT lung cancer
12
13
Bil
d: ©
Jon
as G
laub
itz
- Fo
toli
a.co
m
Da VinciCampus Kiel also introduced the Da Vinci surgery in Europe for the first time for use in urology, general surgery and gynecology. Radical prostatectomy, i.e. prostate removal is performed with the Da Vinci system as well as kidney tumor surgery, cystectomy (removal of the cancer-affected bladder) and other interventions (for example, Pyeloplastiken). Future-oriented treatments in Urology will be used at Kiel in other areas: For example, by surgery metastases in patients with advanced cancer. Work on the extended lymphadenectomy and salvage lymph node surgery for prostate cancer has amazed urologists around world. The success of operations speaks for itself; because the patients are living longer and the complication rate is less than one might think.
Urological TumorsGreat emphasis is placed on the treatment of urological tumors in minimally invasive and laparoscopic surgical procedures (keyhole surgery). This gentle intervention on small sections allows speedy recovery. A complete removal of the kidney with renal tumors is not always necessary. Often, the tumor can be operated in such a way that the organ is preserved, which has favorable affect on the patient’s prognosis. In advanced bladder tumors that require complete removal of the bladder, a bladder replacement will take place with a neobladder, whenever possible and appropriate. Furthermore, there is a special prostate laser (Thulium-Laser) available, with which effective and gentle tissue removal is possible. The favorable properties of this laser surgery can be used even when patients are taking blood-thinning medications. Also the treatment of particularly large prostates is possible with this laser.
Urology Campus KielCampus Kiel
Surgeons at workstation
14
15
UKSHUKSHENT
Head and Neck CancerThe ENT clinics at UKSH offer the full range of diagnosis and treatment of head and neck cancer, according to the latest scientific guidelines. The treatment of carcinoma of the oral cavity, pharynx and larynx has evolved from radical surgery to function-preserving treatment. A therapy concept is developed according to the initial diagnosis from our interdisciplinary tumor conferences for each patient. This can be surgery and / or radiation therapy. The chemotherapy plays a less prominent role in head and neck carcinomas. It is used to improve the effect of irradiation, as so-called chemo radiation. Palliative treatment is also used in order to slow the growth of incurable tumors and relieve discomfort.
Surgical treatmentWe carry out the treatment of the primary tumor and growth through customized operations, whenever possible, with the aim of preserving the organ and the avoidance of functional impairments in swallowing and speaking. If surgical removal of cervical lymph nodes, or neck dissection is necessary, we conduct operations with the removal of individual lymph node groups, so that the muscles are preserved and there is no damage to the nerves and blood vessels of the neck. Our priorities include endoscopic tumor surgery. Here, the primary tumor is removed through the mouth under direct vision through the operating microscope and with the aid of a laser. This technique allows very precise and bloodless tumor removal.
RadiotherapyIn addition to surgery, radiation therapy (radiotherapy) is used in the treatment of head and neck cancer in three situations: First, as a prophylactic treatment to prevent a relapse. Second, in highly advanced tumors, where an operation due to tumor expansion is no longer possible Third, as an alternative to surgery, when a surgically induced loss of function would be connected to an unacceptable restriction of the quality of life.
16
17
Bil
d: ©
Jon
as G
laub
itz
- Fo
toli
a.co
m
UKSHUKSH
Dermatology
Skin CancerBasal cell carcinoma is the most common tumor of the skin. It occurs mainly in basal cell carcinoma on chronic sun-exposed head and neck regions together with the squamous cell carcinoma of the skin and the Merkel cell carcinoma. The treatment of choice is microscopically controlled surgery with systematic histological 3D edge cut control. This has led to a significant reduction in the recurrence rate. The skin clinics of UKSH use this treatment process at the highest level. The process ensures optimal cosmetic surgery results. In superficial variants of basal cell carcinoma and squamous cell carcinoma in certain circumstances surgical treatment is not the best option. For these situations, photodynamic therapy, laser ablation or topical chemotherapy and immunotherapy are good available alternatives.
Significant progress has been made in the development of new therapeutic approaches for metastatic melanoma. With targeted therapy, outstanding response rates can be reliably obtained for the appropriate patients.
Rare Skin TumorsBoth skin cancer centers meet the criteria for diagnosis and treatment of rare skin tumors. The centers place a high priority on solid skin tumor surgery. For skin lymphoma in early stages, the treatment choice of different qualities of phototherapy and topical treatments for advanced cases plays a major role together with multimodal therapies and chemotherapy. A special feature of both skin clinics is the application of extracorporeal photopheresis, which is used very successfully in certain skin lymphomas. In this process, mixing a photosensitizer with UVA light, which triggers a series of immunomodulatory effects, irradiates not the skin, but the blood.
18
19
Campus KielCampus Kiel
Neurosurgery
Brain TumorsThe neurosurgery clinics have the full range of diagnostic and therapeutic methods for treatment of brain tumors. In order to represent a tumor as closely as possible before surgery, elaborate tests are necessary. Computed tomography of the head (CCT) is often the first diagnostic step. An accurate image is possible with magnetic resonance imaging (MRI). Besides the exact localization and positional relationship to structures in the cranium, functional studies are possible, for example, in the speech region or the motion region of the brain. In addition, pathways can be marked in the brain.
The structures inside the skull, the brain itself, nerves and blood vessels, are very sensitive and require the greatest possible protection during treatment. The microsurgery procedure as well as the technical support and continued treatment process are aimed at protection of structures.
GlioblastomaGlioblastoma is the most common and malignant brain tumor, it’s produced mainly in the cerebrum. The optimal treatment is surgical removal and additional treatment with combined radio / chemotherapy. With the help of neuronavigation access, surgery can be accurately performed and controlled tumor removal is possible. The fluorescent label helps to selectively remove the tumor. An intraoperative dose of chemotherapy is then possible. By using intraoperative magnetic resonance tomography, distances can be checked. Another building block for complete and safe removal of the tumor is surgery under local anesthesia, the "wax-operation". The patient is under the watch of a neuropsychologist during the procedure and examined for certain neurological functions. Many of these tools are also useful for other gliomas. They are individually compiled for each patient.
Tumors in ChildrenUnlike adults, intracranial tumors in children are found primarily in the cerebellum and brain stem. Again, there are benign and malignant tumors, and even here the therapy is first to surgically to remove the lesion and to confirm the diagnosis. For our young patients, the excellent interdisciplinary cooperation with specialists in pediatric tumors is ensured at UKSH.
20
21
Bil
d: ©
Jon
as G
laub
itz
- Fo
toli
a.co
m
UKSHUKSH
Hematology
Chronic and Acute LeukemiaThe first diagnosis of acute and chronic leukemia is made on the basis of morphology and cytochemistry of malignant cells from the bone marrow. Then the further subdivision e.g. in B and T lines of affiliation in acute lymphoblastic leukemia (ALL) or the delimitation of chronic lymphocytic leukemia (CLL) is performed to characterize leukemic lymphoma by immunophenotypic. The diagnosis and classification of malignant lymphomas requires the removal or biopsy of an affected lymph node for histological diagnosis. To this end, the close cooperation with the Department of Human Genetics at UKSH provides optimal conditions.
The laboratory for hematological special diagnostics at Campus Kiel has significantly developed special diagnostics as part of a scientific project and is now active as a national and international reference center for many clinical studies. Each year over 12,000 blood and bone marrow samples from patients from all over Germany and from abroad are examined in the laboratory with special hematological diagnostics. The use of the MRD diagnosis for therapy control is groundbreaking and provides individualized therapy management for patients with leukemia and lymphoma.
Many leukemia and malignant lymphomas are now curable or can be controlled in the long term and into adulthood through modern therapeutic concepts. Modern treatment methods consist of both drug chemo-immunotherapy and radiotherapy units. Our patients also have access to innovative therapeutic approaches by participating in clinical trials. At both UKSH Campuses Lübeck and Kiel, it is possible to have an autologous or allogeneic bone marrow and blood stem cell transplantation.
Leukemia and Childhood CancerDespite the improved chances of recovery, the diagnoses of "leukemia" or "cancer" in a child has not yet lost its horror. Fortunately, this diagnosis is made no more than 2,000 times a year in Germany. Cancer in children is a rare disease. In contrast to adults with cancer, cancer in children usually occurs with very dynamic, sometimes dramatic symptoms. Therefore, the diagnosis must be comprehensive and targeted, precise but quickly carried out. The treatment can be initiated quickly for children according to current guidelines of national treatment trials for all malignancies.UKSH has children's hospitals in Lübeck and Kiel. The special stations have experienced doctors and pediatric nurses for leukemia and cancer treatment for children. The clinic offers all therapeutic methods, including autologous and - in Kiel - allogeneic blood stem cell transplantation. Selected patients, primarily those with fortunately rare disease relapses are offered alternative and sometimes-experimental treatment approaches with so-called "new drugs," for example, with an immunotherapeutic drug.Treatment focus is on acute leukemia: The Kiel Department of General Pediatrics has the largest European study group for treatment of ALL in childhood. The clinic acts as a national reference center for the diagnostic evaluation of patient samples (over 5,000 per year), covering all clinical and diagnostic data and also advises many other clinics in Germany.
22
23
Campus LübeckCampus LübeckRadiology, Nuclear Medicine and Radiotherapy
Radiology and Nuclear Medicine
Radiology plays a crucial role in treating oncology patients. On one side, there is the accurate assessment of the tumor’s extent with an imaging condition for a phase-adapted therapy, on the other side, a tumor may be treated by interventional radiological treatment or be prepared for an intervention by surgical therapy. This requires a high level of diagnostic and interventional expertise, an array of modern equipment and close interdisciplinary exchange. The Department of Radiology and Nuclear Medicine at the Campus Lübeck and the Department of Radiology and Neuroradiology at Campus Kiel are technically equipped to the highest university standards. In Lübeck, two modern 64- or 128-slice CT scanners are available and are able to acquire isotropic from the entire body in a few seconds. The hybrid's nuclear imaging in Lübeck is done by PET / CT (installation 2011) and SPECT / CT (installation 2013) makes it possible to detect tumors in an anatomically exact way with highly specific nuclear medicine tracers. In Kiel, there are two 64-slice CT scanners, a dual-source CT (installation 2013) and a total of five MRT (including 1x 3 Tesla) available. Oncological interventions (2013 installation) offer both percutaneous and trans arterial images with two flat detector angiography units. For image post-processing and reports, a powerful RIS / PACS and innovative software solutions for quantitative analysis (RECIST) are available. The collaboration between radiologists and nuclear medicine provides decisive advantages for PET / CT and SPECT / CT examinations and innovative therapies such as selective internal radiotherapy (SIRT) of liver metastases.
The latest technology for precise and gentle radiation treatments is available in the Departments of Radiotherapy at UKSH. About two-thirds of all patients with cancer receive radiotherapy. It is usually well tolerated (often better than large operations or drugs), and older patients for whom surgery would be too risky, can be treated with radiation. UKSH has one of the largest radiation therapy facilities in Germany and provides all radiotherapy at routine treatments (for example, three-dimensional conformational
irradiation, IMRT, image-guided radiotherapy). In addition, numerous special treatments are possible, for example, APBI and the treatment of head and neck cancer by brachytherapy, seed therapy for prostate cancer, radiosurgery, full radiation, treatment in controlled respiratory arrest (as in left-sided breast cancer to heart protection) and other methods. Outpatient and inpatient chemo radiation (combination of radiation and radiation effectively enhancing drugs) is a special focus at UKSH. At Campus Lübeck the only "cone-beam" CT in Northern Germany is used in brachytherapy.
Radiosurgery Campus LübeckNeurosurgery is the high-precision radiation therapy of small tumors. The UKSH is one of the first clinics in Germany who routinely used this procedure since the mid-90s. Campus Lübeck has excellent facilities (an ExacTrac positioning system for high precision radiation therapy). We cooperate with the CyberKnife center in Güstrow among others and treat selected patients there.
Tumor Genetics in OncologyCancer originates from changes in genetic material. With most forms of cancer, the sporadic tumors and the gene modifications in the malignant cells are limited. In contrast to these sporadic forms, 5 to 10 percent of all cancers occur from a genetic predisposition for tumors that can be inherited from parents and passed down to children. A familial predisposition for gene mutation is associated with increased risk of cancers in all body cells. The detection of genetic changes, which is done by UKSH Technologies with the latest "next generation sequencing," plays an increasingly important part in prevention, screening, early detection, treatment and aftercare of cancer. It is the prerequisite for individualized care for people with an increased risk of cancer and for targeted precision therapy. In the Departments of Human Genetics of UKSH, healthy and diseased patients seeking advice will be advised on all matters of cancers in the context of genetic alterations.
24
Department of
General Pediatrics
Clinic director: Prof. Dr. med. Martin Schrappe
Department of
General and Thoracic Surgery
Clinic director: Prof. Dr. med. Thomas Becker
Department of
Dermatology, Venerology and Allergology
Clinic director: Prof. Dr. med. Thomas Schwarz
Department of
Gynecology and Obstetrics
Clinic director: Prof. Dr. med. Nicolai Maass
Department of
Otorhinolaryngology, Head and Neck Surgery
Clinic director: Prof. Dr. med. Petra Ambrosch
Department of
I. Department of Medicine (Gastroenterology, Hepatology, Gerontology)
Clinic director: Prof. Dr. med. Stefan Schreiber
Department of
Department of Medicine II
Clinic director: Prof. Dr. med. Dr. rer. nat. Michael Kneba
Institute of
Experimental Tumor Research
Institute direktor: N.N.
Departments and inst itutes , K iel Campus
Institute of
Human Genetics
Institute direktor: Prof. Dr. med. Reiner Siebert
Department of
Dental, Oral and Maxillofacial Surgery
Clinic director: Prof. Dr. med. Dr. med. dent. Jörg Wiltfang
Institute of
Pathology
Institute direktor: Prof. Dr. med. Christoph Röcken
Department of
Neuroradiology
Clinic director: Prof. Dr. med. Olav Jansen
Department of
Radiation Oncology
Clinic director: Prof. Dr. med. Jürgen Dunst
Department of
Urology
Clinic director: Prof. Dr. med. Klaus-Peter Jünemann
Onkology Centre Campus Kiel
Center director: Prof. Dr. med. Christoph Röcken
Sport and Kinesitherapy
Registration: Dr. phil. Thorsten Schmidt
Krebszentrum Nord
25
Department of
General Surgery
Clinic director: Prof. Dr. med. Tobias Keck
Division of
Translational Surgical Oncology & biobanks
Head of division: Prof. Dr. Dr. med. Jens K. Habermann
Department of
Dermatology, Allergology and Venerology
Clinic director: Prof. Dr. med. Detlef Zillikens
Department of
Gynecology and Obstetrics
Clinic director: Prof. Dr. med. Achim Rody
Department of
Ear, Nose and Throat Medicine
Clinic director: Prof. Dr. med. Barbara Wollenberg
Department of
Pediatric Medicine
Clinic director: Prof. Dr. med. Egbert Herting
Department of
Neurosurgery
Clinic director: Prof. Dr. med. Volker Tronnier
Department of
Urology
Clinic director: Prof. Dr. med. Axel S. Merseburger
Departments and inst itutes , Lübeck Campus
Department of
I. Dep. of Medicine - Internal Medicine
Acting clinic director: Prof. Dr. med. Steinhoff
Department of
III. Dep. of Medicine - Pulmology
Clinic director: Prof. Dr. med. Peter Zabel
Institute of
Human Genetics
Institute director: Prof. Dr. med. Gabriele Gillessen-Kaesbach
Institute of
Pathology
Institute director: Prof. Dr. med. Sven Perner
Department of
Radiation Oncology
Head of department: Prof. Dr. med. Dirk Rades
Department of
Radiology and Nuclearmedicine
Clinic director: Prof. Dr. med. Jörg Bark Buildingen
26
Dip. Psych. Nicole Hanna Meyer
Supervisor
UKSH International
+49 431 500 - 10 730
General contact:
+49 431 500 - 0
www.uksh.de/international_department/en/
Mailing Address:
University Medical Center Schleswig-Holstein
UKSH International
Campus Kiel / Lübeck
Arnold-Heller-Straße 3
24105 Kiel - Germany
UKSHUKSHContact UKSH International
